Lab
Ivette C Cruz Cabrera
Ivette C Cruz Cabrera was paid $513K by Medicaid between Jan 2018 and Feb 2024, across 38 billing codes. Its largest line is G2023, Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source — 17% of everything it billed.
33Billing provider infoIVETTE C CRUZ CABRERA
CAMUY, PR 00627
CAMUY, PR 00627
33aNPI1477806149assigned 10/18/2012
33bProvider typeClinical Medical Laboratory
28Total paid$513K
24GClaims37,922
24DCodes billed38
24AFirst – last monthJan 2018 – Feb 2024
Compared with peers
Next to other Clinical Medical Laboratory providers in Puerto Rico
Rank by total paid#249 of 777
Median peer was paid$278K
This provider vs. median1.8×
Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.
Box 24A · Dates of service
Paid by month
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
| Year | Claims | Paid | |
|---|---|---|---|
| 2018 | 5,497 | $47K | |
| 2019 | 3,087 | $23K | |
| 2020 | 5,937 | $100K | |
| 2021 | 10,351 | $167K | |
| 2022 | 8,354 | $139K | |
| 2023 | 4,681 | $37K | |
| 2024incomplete | 15 | $116.55 |
Box 24 · Service lines
What it billed for
| Code | Service | Share | Claims | Bene. records | Paid |
|---|---|---|---|---|---|
| G2023 | Specimen collection for severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), any specimen source | 17% | 3,633 | 3,180 | $88K |
| 87426 | Infectious agent antigen detection, SARS-CoV-2 (COVID-19) | 17% | 2,232 | 1,923 | $88K |
| 87635 | Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe | 15% | 1,492 | 1,375 | $76K |
| 84443 | Thyroid stimulating hormone (TSH) | 8.2% | 2,986 | 2,838 | $42K |
| 80061 | Lipid panel | 6.7% | 2,956 | 2,826 | $34K |
| 85025 | Blood count; complete (CBC), automated, and automated differential WBC count | 5.8% | 4,625 | 4,295 | $30K |
| 80053 | Comprehensive metabolic panel | 5.8% | 3,411 | 3,196 | $30K |
| 86328 | 4.6% | 947 | 895 | $24K | |
| 82306 | Vitamin D; 25 hydroxy, includes fraction(s), if performed | 4.5% | 919 | 873 | $23K |
| 83036 | Hemoglobin; glycosylated (A1C) | 3.1% | 1,923 | 1,836 | $16K |
| 36415 | Collection of venous blood by venipuncture | 2.2% | 5,413 | 4,890 | $11K |
| 82274 | 1.9% | 706 | 674 | $10K |
26 more codes
| 81001 | 1.7% | 2,924 | $9K | |
| 86738 | 1.2% | 539 | $6K | |
| 82043 | 1.0% | 962 | $5K | |
| 84153 | <1% | 192 | $3K | |
| 84439 | <1% | 352 | $3K | |
| 87804 | Infectious agent antigen detection by immunoassay; Influenza, each type | <1% | 157 | $3K |
| 87276 | <1% | 213 | $3K | |
| 87275 | <1% | 213 | $3K | |
| 86701 | <1% | 113 | $991.66 | |
| 82607 | <1% | 78 | $836.98 | |
| 81000 | <1% | 238 | $784.91 | |
| 86703 | <1% | 86 | $754.95 | |
| 84436 | <1% | 142 | $717.95 | |
| 80048 | Basic metabolic panel (calcium, ionized) | <1% | 76 | $563.30 |
| 84479 | <1% | 106 | $501.49 | |
| 87591 | Infectious agent detection by nucleic acid; Neisseria gonorrhoeae, amplified probe | <1% | 13 | $400.58 |
| 87491 | Infectious agent detection by nucleic acid; Chlamydia trachomatis, amplified probe | <1% | 14 | $382.51 |
| 87088 | <1% | 39 | $259.62 | |
| P9604 | Travel allowance one way in connection with medically necessary laboratory specimen collection drawn from home bound or nursing home bound patient; prorated trip charge | <1% | 13 | $222.17 |
| 85651 | <1% | 75 | $219.86 | |
| 86803 | <1% | 18 | $155.64 | |
| 86592 | <1% | 46 | $134.20 | |
| 82947 | <1% | 28 | $104.98 | |
| 82570 | <1% | 17 | $66.68 | |
| 85730 | <1% | 12 | $62.46 | |
| 85610 | <1% | 13 | $41.23 |
Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.
From NPPES
Who's on the registration
Authorized officialCRUZ CABRERA, IVETTE (OWNER)